Arteris (AIP) director Raza sells 90,000 shares via 10b5-1 trading plan

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Arteris, Inc. director Saiyed Atiq Raza reported an open‑market sale of 90,000 shares of Common Stock for a weighted average price of $28.713 per share. The sale was executed on May 1, 2026 under a pre‑arranged Rule 10b5‑1 trading plan adopted on November 7, 2025.

The sold shares are held indirectly through the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust, where Raza serves as trustee, and this trust held 210,000 shares after the transaction. Separately, Raza directly held 20,839 shares of Arteris common stock following the reported transactions.

Insider Trade Summary 10b5-1

Net Seller: 90,000 shares ($2,584,170)

Net Sell 2 txns

Insider RAZA SAIYED ATIQ

Role null

Sold 90,000 shs ($2.58M)

Type	Security	Shares	Price	Value
Sale	Common Stock	90,000	$28.713	$2.58M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 210,000 shares (Indirect, Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012); Common Stock — 20,839 shares (Direct, null)

Footnotes (1)

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025. 2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.07 to $29.33 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 3. The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the Reporting Person serves as trustee.

Key Figures

Shares sold: 90,000 shares Weighted average sale price: $28.713 per share Sale price range: $28.07–$29.33 per share +2 more

5 metrics

Shares sold 90,000 shares Open-market sale on May 1, 2026

Weighted average sale price $28.713 per share Common Stock sale on May 1, 2026

Sale price range $28.07–$29.33 per share Price range for multiple trade executions

Indirect shares after sale 210,000 shares Held by 2012 Revocable Trust after transaction

Direct shares after transactions 20,839 shares Directly held by Raza following reported transactions

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, Revocable Trust, open-market sale

4 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"The price reported in Column 4 is a weighted average sale price."

Revocable Trust financial

"The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the Reporting Person serves as trustee."

A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 Insider Transactions: What Each Field Means →

05/04/2026 - 05:05 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RAZA SAIYED ATIQ

(Last)

(First)

(Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL

CALIFORNIA

95008

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/01/2026		S⁽¹⁾		90,000	D	$28.713⁽²⁾	210,000	I	Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012⁽³⁾
Common Stock								20,839	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. 1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025.

2. 2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.07 to $29.33 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. 3. The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the Reporting Person serves as trustee.

	/s/ Paul Alpern, as Attorney-in-Fact for S. Atiq Raza	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Arteris (AIP) director Saiyed Atiq Raza report in this Form 4?

He reported an open-market sale of 90,000 Arteris common shares at a weighted average price of $28.713 on May 1, 2026. The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted in November 2025.

At what prices were the Arteris (AIP) shares sold in this transaction?

The reported weighted average sale price was $28.713 per share, with individual trades occurring between $28.07 and $29.33. The filing notes that detailed trade-by-trade pricing information is available from the reporting person upon request.

How many Arteris (AIP) shares does the trust associated with Raza hold after the sale?

After the reported transaction, the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust held 210,000 shares of Arteris common stock. These shares are reported as indirectly owned, with Raza serving as trustee of the trust.

How many Arteris (AIP) shares does Saiyed Atiq Raza hold directly after the filing?

Following the reported transactions, Saiyed Atiq Raza directly held 20,839 shares of Arteris common stock. This direct holding is separate from the 210,000 shares held indirectly through the 2012 Revocable Trust reported in the same Form 4.

Was the Arteris (AIP) insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the 90,000-share sale was made under a Rule 10b5-1 trading plan adopted on November 7, 2025. Such plans allow insiders to pre-schedule trades, helping separate trading decisions from day-to-day market developments.

Who is the actual holder of the indirectly owned Arteris (AIP) shares?

The indirectly owned shares are held by the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust. The Form 4 explains that Raza serves as trustee of this revocable trust, which held 210,000 Arteris shares after the reported sale.